11 C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhage
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The in vivo diagnosis of cerebral amyloid angiopathy (CAA) is inferred from clinical and structural imaging features. (11)C-Pittsburgh compound B (PIB) is a PET ligand that binds to beta-amyloid in extracellular plaques and vessel walls. We hypothesized that patients with a clinical diagnosis of CAA-related hemorrhage (CAAH) have increased (11)C-PIB uptake and that the pattern differs from Alzheimer disease (AD). METHODOLOGY: Patients with CAAH based on established clinical criteria were studied using (11)C-PIB PET and were compared with age-matched controls and patients with AD. Distribution volume ratio (DVR) parametric maps were created using the cerebellar cortex as a reference region. RESULTS: Twelve patients with CAAH of mean age 73.9 (range 58-93) years were compared with 22 normal controls and 13 patients with AD of mean age 71.8 (59-83) and 73.8 (56-90) years, respectively. CAAH PIB median DVR binding was higher in cortical regions (1.69, interquartile range 1.44-1.97) compared with controls (1.32, 1.21-1.44, p = 0.002) but lower than AD (2.04, 1.93-2.26, p = 0.004). The occipital-global uptake ratio was lower among patients with AD than among patients with CAAH (p = 0.008), and the frontal-global uptake ratio was higher (p = 0.012). CONCLUSION: (11)C-Pittsburgh compound B (PIB) binding is moderately increased in most patients with probable cerebral amyloid angiopathy (CAA)-related intracerebral hemorrhage. The distribution may differ from that seen in Alzheimer disease. (11)C-PIB PET may assist in the in vivo diagnosis of CAA and serve as a surrogate marker for future therapeutic studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pittsburgh Compound B retention is not specific for CAA as opposed to Alzheimer disease, because the compound binds to both vascular and parenchymal amyloid158; however, the 2 pathologies may be distinguishable in part by the relative occipital predominance of labeling in CAA.156,157”
In the citing paper
“Other potential diagnostic approaches have been explored, including detection of reduced Aβ in cerebrospinal fluid155 or increased retention of the amyloid ligand Pittsburgh Compound B on positron emission tomography imaging.156,157”
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Self-citationCerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,071
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
Mathis, C. A., Wang, Y., Holt, D. P., Huang, G.-F., Debnath, M. L., & Klunk, W. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030026b · Cited by 979
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2109 · Cited by 880
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review
Jorm, A. F. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000390 · Cited by 823
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
Price, J. C., Klunk, W. E., Lopresti, B. J., Lu, X., Hoge, J. A., Ziolko, S. K., Holt, D. P., Meltzer, C. C., DeKosky, S. T., & Mathis, C. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600146 · Cited by 720
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A., Ringheim, A., Langstrom, B., & Nordberg, A. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 617
Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
Lopresti, B. J., Klunk, W. E., Mathis, C. A., Hoge, J. A., Ziolko, S. K., Lu, X., MELTZER, C. C., Schimmel, K., Tsopelas, N. D., DeKosky, S. T., et al. (2005) · PubMed · Cited by 543
Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy
Greenberg, S. M., William Rebeck, G., Vonsattel, J. P. G., Gomez‐Isla, T., & Hyman, B. T. (1995) · Annals of Neurology · doi:10.1002/ana.410380219 · Cited by 541
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
Greenberg, S. M., Eng, J. A., Ning, M., Smith, E. E., & Rosand, J. (2004) · Stroke · doi:10.1161/01.str.0000126807.69758.0e · Cited by 507
Vinters, H. V., & Gilbert, J. J. (1983) · Stroke · doi:10.1161/01.str.14.6.924 · Cited by 504
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495
A row-action alternative to the EM algorithm for maximizing likelihood in emission tomography
Browne, J., & de Pierro, A. B. (1996) · IEEE Transactions on Medical Imaging · doi:10.1109/42.538946 · Cited by 424
Cerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications
Koennecke, H.-C. (2006) · Neurology · doi:10.1212/01.wnl.0000194266.55694.1e · Cited by 373
Molecular Imaging With Pittsburgh Compound B Confirmed at Autopsy: A Case Report
Bacskai, B. J., Frosch, M. P., Freeman, S. H., Raymond, S. B., Augustinack, J. C., Johnson, K. A., Irizarry, M. C., Klunk, W. E., Mathis, C. A., DeKosky, S. T., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.431 · Cited by 341
Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study
Pfeifer, L. A., White, L. R., Ross, G. W., Petrovitch, H., & Launer, L. J. (2002) · Neurology · doi:10.1212/wnl.58.11.1629 · Cited by 338
Pettersen, J. A., Sathiyamoorthy, G., Gao, F.-Q., Szilagyi, G., Nadkarni, N. K., St George-Hyslop, P., Rogaeva, E., & Black, S. E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.6.790 · Cited by 264
Greenberg, S. M., Briggs, M. E., Hyman, B. T., Kokoris, G. J., Takis, C., Kanter, D. S., Kase, C. S., & Pessin, M. S. (1996) · Stroke · doi:10.1161/01.str.27.8.1333 · Cited by 259
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy
Rosand, J., Muzikansky, A., Kumar, A., Wisco, J. J., Smith, E. E., Betensky, R. A., & Greenberg, S. M. (2005) · Annals of Neurology · doi:10.1002/ana.20596 · Cited by 244
Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease
Vinters, H. V., Wang, Z. Z., & Secor, D. L. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00799.x · Cited by 171
Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage
McCarron, M. O., & Nicoll, J. A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00825-7 · Cited by 169
Cerebral Amyloid Angiopathy in the Elderly
Tomonaga, M. (1981) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1981.tb01757.x · Cited by 156
Cosgrove, G. R., Leblanc, R., Meagher-Villemure, K., & Ethier, R. (1985) · Neurology · doi:10.1212/wnl.35.5.625 · Cited by 96
Intracranial Hemorrhage after Use of Tissue Plasminogen Activator for Coronary Thrombolysis
Kase, C. S., O'Neal, A. M., Fisher, M., Girgis, G. N., & Ordia, J. I. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-1-17 · Cited by 92
[Cerebral amyloid angiopathy].
Almas, T., Vedeler, C. A., Moen, G., & Mörk, S. (1998) · PubMed · Cited by 87
Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy.
Gervais, F., Chalifour, R. J., Garceau, D., Kong, X., Laurin, J., McLaughlin, R. W., Morissette, C., & Paquette, J. (2001) · PubMed · Cited by 83
Intracerebral hemorrhage related to cerebral amyloid angiopathy and T‐PA treatment
Pendlebury, W. W., Iole, E. D., Tracy, R. P., & Ba, B. A. D. (1991) · Annals of Neurology · doi:10.1002/ana.410290216 · Cited by 53
A Phase 2 Study of Tramiprosate for Cerebral Amyloid Angiopathy
Greenberg, S. M., Rosand, J. M., Schneider, A. T., Pettigrew, L. C., Gandy, S., Rovner, B. W., Fitzsimmons, B., Smith, E. E., Gurol, M. E., Schwab, K. M., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213845.28624.f4 · Cited by 52
Dementia in cerebral amyloid angiopathy: a clinicopathological study
Yoshimura, M., Yamanouchi, H., Kuzuhara, S., Mori, H., Sugiura, S., Mizutani, T., Shimada, H., Tomonaga, M., & TOYOKURA, Y. (1992) · Journal of Neurology · doi:10.1007/bf00856809 · Cited by 52
Cerebral Hemorrhage from Amyloid Angiopathy and Coronary Thrombolysis
Leblanc, R., Haddad, G., & Robitaille, Y. (1992) · Neurosurgery · doi:10.1227/00006123-199209000-00025 · Cited by 41
Fatal Streptokinase-Induced Intracerebral Haemorrhage in Cerebral Amyloid Angiopathy
Ramsay, D. A., Penswick, J. L., & Robertson, D. M. (1990) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100030705 · Cited by 37
Subpial peptide deposits are closely associated with amyloid angiopathy in the elderly
Itoh, Y., Yamada, M., Hayakawa, M., Otomo, E., & Miyatake, T. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90693-f · Cited by 7
Research works printed but not linked: 2
- Glenner GG, Henry JH, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1981;1:120–129.
- Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci 2005;229–230:37–41.
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Cerebral amyloid angiopathy in the elderly
Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643
Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611
“162 Ly et al demonstrated that CAA subjects had increased global PiB uptake relative to a healthy elderly control group, and found an occipital predominance of PiB retention in CAA compared with AD.”
ResultVascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603
“edium arteries) pic (medium/small Angiography Vascular Doppler examination Carotid intimal-media thickness Not directly visible Amyloid ligand imaging [78,79]”
BackgroundDichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
Metadata
- Authors
- Ly, J. V., Donnan, G. A., Villemagne, V. L., Zavala, J. A., Ma, H., O'Keefe, G., Gong, S. J., Gunawan, R. M., Saunder, T., Ackerman, U., Tochon-Danguy, H., Churilov, L., Phan, T. G., & Rowe, C. C.
- Affiliations
- The University of Melbourne (AU)
- From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia.
- ORCID
- Venue
- Neurology
- Published
- 2010-02-09
- Volume
- 74
- Issue
- 6
- Pages
- 487-493
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2075078231
- Cited by
- 157
- References
- 38
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 12 · 2016: 11 · 2015: 14 · 2014: 16 · 2013: 11 · 2012: 22
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Chinese Academy of Agricultural Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- cerebral amyloid angiopathy, intracerebral hemorrhage, 11C-Pittsburgh compound B, amyloid PET, Alzheimer's disease, distribution volume ratio, in vivo diagnosis
- MeSH terms
- Aged, Aged, 80 and over, Aniline Compounds, Carbon Radioisotopes, Female, Hemorrhage, Humans, Magnetic Resonance Imaging, Male, Mental Status Schedule, Middle Aged, Prospective Studies, Surveys and Questionnaires, Retrospective Studies, Thiazoles, Cerebral Amyloid Angiopathy, Positron-Emission Tomography, Benzothiazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.